ESC 365 - Discussant review - ATTR-ACT.

ESC Premium Access

Discussant review - ATTR-ACT.

Session: Hot Line Session 3

Topic: Neurologic Disorders and Heart Disease

Speaker: Professor J. George (Rehovot, IL)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Jacob George

Kaplan Medical Center, Rehovot (Israel)

2 presentations

0 follower

19 more presentations in this session

Opening question - ATTR-ACT Trial.

ATTR-ACT Trial - Efficacy and Safety of Tafamidis in Transthyretin Amyloid Cardiomyopathy

Speaker: Professor C. Rapezzi (Ferrara, IT)

Questions from the audience and discussion.

Concluding question - ATTR-ACT Trial.

Opening question - COMMANDER HF.

Access the full session

Hot Line Session 3

Speakers: Professor J. George, Professor C. Rapezzi

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Related content

Open Access

SGLT2 Inhibitors as a Central Cardio-Renal-Metabolic Therapy: The Modern Day ACE Inhibitor.

29 August 2021

Open Access

GUIDE-HF - Panel discussion.

27 August 2021

Open Access

GUIDE-HF - Discussant review.

27 August 2021

ESC 365 is supported by